Chargement en cours...
Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: Where do we stand?
Liver transplantation (LT) for hepatocellular carcinoma (HCC) within Milan criteria is a widely accepted optimal therapy. Neo-adjuvant therapy before transplantation has been used as a bridging therapy to prevent dropout during the waiting period and as a down-staging method for the patient with int...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017046/ https://ncbi.nlm.nih.gov/pubmed/24833861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i18.5308 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|